Nizamudin, M., M. P. Kumar, A. Gautham, D. K. Sriram, and M. George. “Roflumilast: First Approved Oral Selective PDE4 Inhibitor for the Treatment of COPD”. International Journal of Health and Clinical Research, vol. 3, no. 5, Sept. 2020, pp. 85-89, https://ijhcr.com/index.php/ijhcr/article/view/157.